Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker of disease activity in patients with systemic lupus erythematosus

Authors

  • Aritra Saha Department of Clinical Haematology, King George’s Medical University, Lucknow, Uttar Pradesh, India
  • Ajit Kumar Pegu Department of Medicine, Assam Medical College and Hospital, Dibrugarh, Assam, India
  • Rebecca R. Marak Department of Medicine, Lakhimpur Medical College and Hospital, Lakhimpur, Assam, India
  • Zarika Ahmed Department of Pathology, Assam Medical College and Hospital, Dibrugarh, Assam, India
  • Mayuree Thakuria Department of Medicine, Assam Medical College and Hospital, Dibrugarh, Assam, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243060

Keywords:

SLE, NLR, PLR, SLEDAI-2K

Abstract

Background: Systemic lupus erythematosus (SLE) is a female predominant multiple system involving autoimmune inflammatory disorder. Considering the affordability and wide availability of the recently studied marker of inflammation neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), this study was done to investigate the relationship between NLR and PLR with the disease activity in patients with SLE.

Methods: In this hospital based cross sectional study done in Assam medical college and hospital, Dibrugarh done over one year period, newly diagnosed SLE patients above the age of 13 years were included. Patients with underlying disorders or on medications that may affect cell counts, drug induced lupus and recent history of blood transfusion were excluded. The disease activity was calculated using SLE disease activity index 2000 (SLEDAI-2K) and the patients were divided in two groups, group-A (SLEDAI-2K score <9) and group-B (SLEDAI-2K score >9) and correlation was sought with NLR and PLR.

Results: In this study 49 patients were included, with a mean age of 26.33 years and a female predominance (98%). NLR was found to be higher in group-B (11.37 vs 8.05, p<0.001) and NLR positively correlated with SLEDAI-2K score (p<0.001), ESR (p<0.001) and CRP (p=0.212). PLR had a positive correlation with SLEDAI-2K score, CRP, and ESR, although it was the correlation with ESR that was statistically significant (p=0.029).

Conclusions: NLR and PLR was found to have a positive correlation with SLEDAI-2K scores, CRP and ESR and therefore can serve as an inexpensive marker of disease activity in patients with SLE.

Metrics

Metrics Loading ...

References

Justiz Vaillant AA, Goyal A, Varacallo M. Systemic Lupus Erythematosus. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022.

Mallavarapu RK, Grimsley EW. The history of lupus erythematosus. South Med J. 2007;100(9):896-8.

Systemic lupus erythematosus. Edi Lahita RG. New York, John Wiley and sons. 1986;1000.

The History of Lupus Erythematosus and Discoid Lupus: FromHippocrates to the Present. Available at: https://www.longdom.org/open-access/the-history-of-lupus-erythematosus-and-discoid-lupus-fromhippocrates-to-the-present-42667.html. Accessed on 10 June 2024.

Osler W. Classics: On the visceral complications of erythema exudativum multiforme. William Osler, M.D., F.R.C.P. Lond. Am J Med Sci. 1976;271(1):106-17.

Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Med J. 2021;122(07):474-88.

Saigal R, Kansal A, Mittal M, Singh Y, Maharia H, Juneja M. Clinical profile of systemic lupus erythematosus patients at a tertiary care centre in Western India. JIACM. 2011;1:27-32.

Dhakate T, Rajadhyaksha A, Panjwani R. Study of Clinical profile of newly diagnosed lupus nephritis in case of systemic lupus erythematosus. Int J Health Clin Res. 2021;4(10):111-4.

Santhanam S, Mani M, Tamilselvam TN, Rajeswari S. Clinical and immunological profile of SLE patients: Experience from a Chennai-based tertiary care centre (revisited). Internet J Rheumatol Clin Immunol. 2016;4(1):1-5.

Wu Y, Chen Y, Yang X, Chen L, Yang Y. Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 2016;36:94-9.

Nightingale AL, Davidson JE, Molta CT, Kan HJ, McHugh NJ. Presentation of SLE in UK primary care using the Clinical Practice Research Datalink. Lupus Sci Med. 2017;4(1):e000172.

Jagdish GA, Va L, Seema LH. Clinico-immunological Profile of Systemic Lupus Erythematosus: An Observational Study. J Assoc Physicians India. 2022;70(3):11-12.

Talukdar D, Akash PG, Daisy D, Rebecca RM, Sanjeeb K, Vandana P, et al. The clinical and immunological profiles of systemic lupus erythematosus patients from Assam, North-East India. J Indian Rheumatol Asso 2020;15(3):10.

Ramírez Sepúlveda JI, Bolin K, Mofors J, Leonard D, Svenungsson E, Jönsen A, et al. Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ. 2019;10(1):1-7.

Koelmeyer R, Nim HT, Nikpour M, Sun YB, Kao A, Guenther O, et al. High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus. Lupus Sci Med. 2020;7(1):e000372.

Wu L, Zou S, Wang C, Tan X, Yu M. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in Chinese Han population from Chaoshan region in South China. BMC Cardiovasc Disord. 2019;19(1):125.

Soliman WM, Sherif NM, Ghanima IM, EL-Badawy MA. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis. Reumatol Clínica. 2020;16(4):255-61.

Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372-6.

Yu H, Jiang L, Yao L, Gan C, Han X, Liu R, et al. Predictive value of the neutrophil‑to‑lymphocyte ratio and hemoglobin insystemic lupus erythematosus. Exp Ther Med. 2018;16(2):1547-53.

Yolbas S, Yildirim A, Gozel N, Uz B, Koca SS. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet’s Disease. Med Princ Pract. 2016;25(6):510-6.

Xie S, Chen X. Red blood cell distribution width-to-platelet ratio as a disease activity-associated factor in systemic lupus erythematosus. Medicine (Baltimore). 2018;97(39):e12342.

Ma L, Zeng A, Chen B, Chen Y, Zhou R. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with systemic lupus erythematosus and their correlation with activity: A meta-analysis. Int Immunopharmacol. 2019;76:105949.

Kim HA, Jung JY, Suh CH. Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus. Clin Rheumatol. 2017;36(11):2479-85.

Downloads

Published

2024-10-24

How to Cite

Saha, A., Pegu, A. K., Marak, R. R., Ahmed, Z., & Thakuria, M. (2024). Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as a marker of disease activity in patients with systemic lupus erythematosus. International Journal of Advances in Medicine, 11(6), 571–577. https://doi.org/10.18203/2349-3933.ijam20243060

Issue

Section

Original Research Articles